Please use this identifier to cite or link to this item: https://doi.org/10.1093/hmg/ddv340
Title: F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy
Authors: Zhou Z.D. 
Xie S.P.
Sathiyamoorthy S.
Saw W.T.
Sing T.Y.
Ng S.H.
Chua H.P.H.
Tang A.M.Y.
Shaffra F.
Li Z.
Wang H.
Ho P.G.H.
Lai M.K.P. 
Angeles D.C. 
Lim T.M.
Tan E.-K. 
Issue Date: 2015
Publisher: Oxford University Press
Citation: Zhou Z.D., Xie S.P., Sathiyamoorthy S., Saw W.T., Sing T.Y., Ng S.H., Chua H.P.H., Tang A.M.Y., Shaffra F., Li Z., Wang H., Ho P.G.H., Lai M.K.P., Angeles D.C., Lim T.M., Tan E.-K. (2015). F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy. Human Molecular Genetics 24 (22) : 6314-6330. ScholarBank@NUS Repository. https://doi.org/10.1093/hmg/ddv340
Abstract: The mutations of F-box protein 7 (FBXO7) gene (T22M, R378G and R498X) are associated with a severe form of autosomal recessive juvenile-onset Parkinson's disease (PD) (PARK 15). Here we demonstrated that wild-type (WT) FBXO7 is a stress response protein and it can play both cytoprotective and neurotoxic roles. The WT FBXO7 protein is vital to cell mitophagy and can facilitate mitophagy to protect cells, whereas mutant FBXO7 inhibits mitophagy. Upon stress, the endogenous WT FBXO7 gets up-regulated, concentrates into mitochondria and forms FBXO7 aggregates in mitochondria. However, FBXO7 mutations aggravate deleterious FBXO7 aggregation in mitochondria. The FBXO7 aggregation and toxicity can be alleviated by Proline, glutathione (GSH) and coenzyme Q10, whereas deleterious FBXO7 aggregation in mitochondria can be aggravated by prohibitin 1 (PHB1), a mitochondrial protease inhibitor. The overexpression of WT FBXO7 could lead to FBXO7 protein aggregation and dopamine neuron degeneration in transgenic Drosophila heads. The elevated FBXO7 expression and aggregation were identified in human fibroblast cells from PD patients. FBXO7 can also form aggregates in brains of PD and Alzheimer's disease. Our study provides novel pathophysiologic insights and suggests that FBXO7 may be a potential therapeutic target in FBXO7-linked neuron degeneration in PD. � The Author 2015. Published by Oxford University Press. All rights reserved.
Source Title: Human Molecular Genetics
URI: http://scholarbank.nus.edu.sg/handle/10635/150116
ISSN: 9646906
DOI: 10.1093/hmg/ddv340
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

14
checked on Aug 19, 2019

WEB OF SCIENCETM
Citations

13
checked on Dec 24, 2018

Page view(s)

61
checked on Aug 15, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.